Skip to main content Accessibility Statement

Investors

At Tactile Medical, a fundamental value is to earn a fair profit and return value for our shareholders

--

Minimum 15 minutes delayed. Source: LSEG

Upcoming Events

FEB 18 2025 5:00 PM EST

Q4 2024 Tactile Medical Earnings Conference Call

FEB 18 2025 5:00 PM EST

Add to Outlook
Add to Google Calendar
Listen to webcast

Recent News

  • February 5, 2025

    Tactile Medical to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 18, 2025

    MINNEAPOLIS , Feb. 05, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that fourth quarter and fiscal year 2024 financial results will be

    Read more

  • February 4, 2025

    Tactile Medical Expands Launch of Nimbl™ to Include Patients with Lower Extremity Lymphedema

    Next-Generation Platform Now Available for Both Upper and Lower Extremity Conditions MINNEAPOLIS , Feb. 04, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic

    Read more

  • January 13, 2025

    Tactile Medical Appoints Laura King to Board of Directors

    MINNEAPOLIS , Jan. 13, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced the appointment of Laura King to the Company’s Board of Directors (“Board”) and as

    Read more